Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides

Gilead Sciences Inc (NASDAQ:GILD) stock is trading lower during the premarket trading session on Wednesday.

According to a Tuesday report in the Wall Street Journal, the Health and Human Services Department (HHS) is considering substantial reductions in federal funding for domestic HIV prevention.

According to people familiar with the matter, the WSJ reports that the plans could be announced within a day. However, they are not final and could still be changed or canceled.

Also Read: Gilead Presents New HIV Treatment And Cure Research Data

The Centers for Disease Control and Prevention (CDC) has a department focused on preventing HIV and other infectious diseases. It provides funding for state and local programs, including HIV tracking, syringe services, and community outreach, the WSJ writes.

Meanwhile, the Trump ...